Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

Benjamin M Ellingson, Lauren E Abrey, Sarah J Nelson, Timothy J Kaufmann, Josep Garcia, Olivier Chinot, Frank Saran, Ryo Nishikawa, Roger Henriksson, Warren P Mason, Wolfgang Wick, Nicholas Butowski, Keith L Ligon, Elizabeth R Gerstner, Howard Colman, John de Groot, Susan Chang, Ingo Mellinghoff, Robert J Young, Brian M Alexander, Rivka Colen, Jennie W Taylor, Isabel Arrillaga-Romany, Arnav Mehta, Raymond Y Huang, Whitney B Pope, David Reardon, Tracy Batchelor, Michael Prados, Evanthia Galanis, Patrick Y Wen, Timothy F Cloughesy

Open source

DOI
10.1093/neuonc/noy053
Published
2018-04-05
Container
Neuro-Oncology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noy053,
  title = {Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma},
  author = {Benjamin M Ellingson and Lauren E Abrey and Sarah J Nelson and Timothy J Kaufmann and Josep Garcia and Olivier Chinot and Frank Saran and Ryo Nishikawa and Roger Henriksson and Warren P Mason and Wolfgang Wick and Nicholas Butowski and Keith L Ligon and Elizabeth R Gerstner and Howard Colman and John de Groot and Susan Chang and Ingo Mellinghoff and Robert J Young and Brian M Alexander and Rivka Colen and Jennie W Taylor and Isabel Arrillaga-Romany and Arnav Mehta and Raymond Y Huang and Whitney B Pope and David Reardon and Tracy Batchelor and Michael Prados and Evanthia Galanis and Patrick Y Wen and Timothy F Cloughesy},
  year = {2018},
  journal = {Neuro-Oncology},
  doi = {10.1093/neuonc/noy053},
  url = {https://doi.org/10.1093/neuonc/noy053}
}

RIS

TY  - JOUR
TI  - Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma
AU  - Benjamin M Ellingson
AU  - Lauren E Abrey
AU  - Sarah J Nelson
AU  - Timothy J Kaufmann
AU  - Josep Garcia
AU  - Olivier Chinot
AU  - Frank Saran
AU  - Ryo Nishikawa
AU  - Roger Henriksson
AU  - Warren P Mason
AU  - Wolfgang Wick
AU  - Nicholas Butowski
AU  - Keith L Ligon
AU  - Elizabeth R Gerstner
AU  - Howard Colman
AU  - John de Groot
AU  - Susan Chang
AU  - Ingo Mellinghoff
AU  - Robert J Young
AU  - Brian M Alexander
AU  - Rivka Colen
AU  - Jennie W Taylor
AU  - Isabel Arrillaga-Romany
AU  - Arnav Mehta
AU  - Raymond Y Huang
AU  - Whitney B Pope
AU  - David Reardon
AU  - Tracy Batchelor
AU  - Michael Prados
AU  - Evanthia Galanis
AU  - Patrick Y Wen
AU  - Timothy F Cloughesy
PY  - 2018
JO  - Neuro-Oncology
DO  - 10.1093/neuonc/noy053
UR  - https://doi.org/10.1093/neuonc/noy053
ER  - 

APA

Ellingson, B. M., Abrey, L. E., Nelson, S. J., Kaufmann, T. J., Garcia, J., Chinot, O., Saran, F., Nishikawa, R., Henriksson, R., Mason, W. P., Wick, W., Butowski, N., Ligon, K. L., Gerstner, E. R., Colman, H., Groot, J. D., Chang, S., Mellinghoff, I., Young, R. J., Alexander, B. M., Colen, R., Taylor, J. W., Arrillaga-Romany, I., Mehta, A., Huang, R. Y., Pope, W. B., Reardon, D., Batchelor, T., Prados, M., Galanis, E., Wen, P. Y., & Cloughesy, T. F. (2018). Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noy053

Source records